{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T04:46:04Z","timestamp":1785818764801,"version":"3.56.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,1,10]],"date-time":"2013-01-10T00:00:00Z","timestamp":1357776000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2013,1,10]],"date-time":"2013-01-10T00:00:00Z","timestamp":1357776000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Introduction<\/jats:title>\n                        <jats:p>Systemic sclerosis (SSc) is more prevalent in women. Our goal is to determine the effects of 17\u03b2-estradiol (E2) on the development of fibrosis and to compare circulating levels of estrogens in SSc patients and healthy controls.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>Using primary human dermal fibroblasts, we evaluated the effect of E2 on fibronectin (FN) expression with and without the estrogen receptor (ER) antagonist ICI 182,780, inhibitors of signaling, propyl-pyrazole-triol, an ER\u03b1 specific ligand, and genistein, an ER\u03b2 selective ligand, to identify the signaling pathways mediating E2's effect. We confirmed the fibrotic effect of E2 in human skin using an <jats:italic>ex vivo<\/jats:italic> organ culture model. Lastly, we measured levels of E2 and estrone in serum samples from SSc patients with diffuse cutaneous involvement and healthy controls using mass spectrometry.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>E2 increased expression of FN in dermal fibroblasts. ICI 182,780, inositol-1,4,5-triphosphate inhibitor, and p38 mitogen-activated protein kinase inhibitor blocked the effects of E2 on FN. Propyl-pyrazole-triol, but not genistein, significantly increased FN expression. <jats:italic>Ex vivo<\/jats:italic>, E2 induced fibrosis of human skin. The effects of E2 were abrogated by ICI 182,780. Circulating levels of E2 and estrone were significantly increased in sera of patients with diffuse cutaneous SSc.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusion<\/jats:title>\n                        <jats:p>Our findings implicate estrogens in the fibrotic process and may explain the preponderance of SSc in women. ICI 182,780 or other ER signaling antagonists may be effective agents for the treatment of fibrosis.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/ar4140","type":"journal-article","created":{"date-parts":[[2013,1,10]],"date-time":"2013-01-10T21:28:57Z","timestamp":1357853337000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Estradiol promotes the development of a fibrotic phenotype and is increased in the serum of patients with systemic sclerosis"],"prefix":"10.1186","volume":"15","author":[{"given":"Keiko","family":"Aida-Yasuoka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Peoples","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidekata","family":"Yasuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Hershberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katelynn","family":"Thiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane A","family":"Cauley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Thomas A","family":"Medsger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol A","family":"Feghali-Bostwick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,1,10]]},"reference":[{"key":"3869_CR1","first-page":"1633","volume-title":"Arthritis and Allied Conditions","author":"RM Silver","year":"2005","unstructured":"Silver RM, Medsger TA, Bolster MB: Systemic sclerosis and scleroderma variants: clinical aspects. Arthritis and Allied Conditions. Edited by: Koopman WJ, Moreland LW. 2005, Philadelphia, PA: Lippincott, Williams & Wilkins, 1633-1680."},{"key":"3869_CR2","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1097\/01.bor.0000181534.67685.5a","volume":"17","author":"KB Highland","year":"2005","unstructured":"Highland KB, Silver RM: New developments in scleroderma interstitial lung disease. Curr Opin Rheumatol. 2005, 17: 734-745.","journal-title":"Curr Opin Rheumatol"},{"key":"3869_CR3","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1172\/JCI27987","volume":"116","author":"BJ Deroo","year":"2006","unstructured":"Deroo BJ, Korach KS: Estrogen receptors and human disease. J Clin Invest. 2006, 116: 561-570. 10.1172\/JCI27987.","journal-title":"J Clin Invest"},{"key":"3869_CR4","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1093\/carcin\/21.3.427","volume":"21","author":"BE Henderson","year":"2000","unstructured":"Henderson BE, Feigelson HS: Hormonal carcinogenesis. Carcinogenesis. 2000, 21: 427-433. 10.1093\/carcin\/21.3.427.","journal-title":"Carcinogenesis"},{"key":"3869_CR5","doi-asserted-by":"publisher","first-page":"4241","DOI":"10.1210\/en.2003-0550","volume":"144","author":"HA Harris","year":"2003","unstructured":"Harris HA, Albert LM, Leathurby Y, Malamas MS, Mewshaw RE, Miller CP, Kharode YP, Marzolf J, Komm BS, Winneker RC, Frail DE, Henderson RA, Zhu Y, Keith JC: Evaluation of an estrogen receptor-beta agonist in animal models of human disease. Endocrinology. 2003, 144: 4241-4249. 10.1210\/en.2003-0550.","journal-title":"Endocrinology"},{"key":"3869_CR6","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1210\/en.142.3.969","volume":"142","author":"PM Wise","year":"2001","unstructured":"Wise PM, Dubal DB, Wilson ME, Rau SW, Bottner M: Minireview. Neuroprotective effects of estrogen: new insights into mechanisms of action. Endocrinology. 2001, 142: 969-973. 10.1210\/en.142.3.969.","journal-title":"Endocrinology"},{"key":"3869_CR7","doi-asserted-by":"publisher","first-page":"2642","DOI":"10.1161\/01.STR.0000143213.02473.f5","volume":"35","author":"PD Hurn","year":"2004","unstructured":"Hurn PD, Sacco RL: Sex, steroids and stroke: introduction. Stroke. 2004, 35: 2642-2643. 10.1161\/01.STR.0000143213.02473.f5.","journal-title":"Stroke"},{"key":"3869_CR8","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1006\/bbrc.2000.3827","volume":"278","author":"C Ohlsson","year":"2006","unstructured":"Ohlsson C, Hellberg N, Parini P, Vidal O, Bohlooly-Y M, Rudling M, Lindberg MK, Warner M, Angelin B, Gustafsson JA: Obesity and disturbed lipoprotein profile in estrogen receptor-alpha-deficient male mice. Biochem Biophys Res Commun. 2006, 278: 640-645.","journal-title":"Biochem Biophys Res Commun"},{"key":"3869_CR9","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1080\/03009740600844498","volume":"35","author":"L Beretta","year":"2006","unstructured":"Beretta L, Caronni M, Origgi L, Ponti A, Santaniello A, Scorza R: Hormone replacement therapy may prevent the development of isolated pulmonary hypertension in patients with systemic sclerosis. Scand J Rheumatol. 2006, 35: 468-471. 10.1080\/03009740600844498.","journal-title":"Scand J Rheumatol"},{"key":"3869_CR10","first-page":"99","volume":"21","author":"CK Thomas-Golbanov","year":"2003","unstructured":"Thomas-Golbanov CK, Wilke WS, Fessler BJ, Hoffman GS: Open label trial of tamoxifen in scleroderma. Clin Exp Rheumatol. 2003, 21: 99-102.","journal-title":"Clin Exp Rheumatol"},{"key":"3869_CR11","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1002\/art.11173","volume":"48","author":"C Feghali-Bostwick","year":"2003","unstructured":"Feghali-Bostwick C, Medsger TA, Wright TM: Analysis of systemic sclerosis in twins reveals low concordance for disease and high concordance for the presence of antinuclear antibodies. Arthritis Rheum. 2003, 48: 1956-1963. 10.1002\/art.11173.","journal-title":"Arthritis Rheum"},{"key":"3869_CR12","doi-asserted-by":"publisher","first-page":"3305","DOI":"10.1002\/art.21355","volume":"52","author":"X Zhou","year":"2005","unstructured":"Zhou X, Tan FK, Xiong M, Arnett FC, Feghali-Bostwick CA: Monozygotic twins clinically discordant for scleroderma show concordance for fibroblast gene expression profiles. Arthritis Rheum. 2005, 52: 3305-3314. 10.1002\/art.21355.","journal-title":"Arthritis Rheum"},{"key":"3869_CR13","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1210\/en.140.2.800","volume":"140","author":"J Sun","year":"1999","unstructured":"Sun J, Meyers MJ, Fink BE, Rajendran R, Katzenellenbogen JA, Katzenellenbogen BS: Novel ligands that function as selective estrogens or antiestrogens for estrogen receptor-alpha or estrogen receptor-beta. Endocrinology. 1999, 140: 800-804. 10.1210\/en.140.2.800.","journal-title":"Endocrinology"},{"key":"3869_CR14","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/S0002-9440(10)62263-8","volume":"166","author":"JM Pilewski","year":"2005","unstructured":"Pilewski JM, Liu L, Henry AC, Knauer AV, Feghali-Bostwick CA: Insulin-like growth factor binding protein 3 and 5 are overexpressed in idiopathic pulmonary fibrosis and contribute to extracellular matrix deposition. Am J Pathol. 2005, 166: 399-407. 10.1016\/S0002-9440(10)62263-8.","journal-title":"Am J Pathol"},{"key":"3869_CR15","doi-asserted-by":"publisher","first-page":"17","DOI":"10.2174\/1874312900802010017","volume":"2","author":"H Yasuoka","year":"2008","unstructured":"Yasuoka H, Larregina AT, Yamaguchi Y, Feghali-Bostwick CA: Human skin culture as an ex vivo model for assessing the fibrotic effects of insulin-like growth factor binding proteins. Open Rheumatol J. 2008, 2: 17-22. 10.2174\/1874312900802010017.","journal-title":"Open Rheumatol J"},{"key":"3869_CR16","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1038\/nm1197-1209","volume":"3","author":"GS Ashcroft","year":"1997","unstructured":"Ashcroft GS, Dodsworth J, van Boxtel E, Tarnuzzer RW, Horan MA, Schultz GS, Ferguson MW: Estrogen accelerates cutaneous wound healing associated with an increase in TGF-\u03b21 levels. Nat Med. 1997, 3: 1209-1215. 10.1038\/nm1197-1209.","journal-title":"Nat Med"},{"key":"3869_CR17","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/S0002-9440(10)65217-0","volume":"155","author":"GS Ashcroft","year":"1999","unstructured":"Ashcroft GS, Greenwell-wild T, Horan MA, Wahl SM, Ferguson MW: Topical estrogen accelerates cutaneous wound healing in aged humans associated with an altered inflammation response. Am J Pathol. 1999, 155: 1137-1146. 10.1016\/S0002-9440(10)65217-0.","journal-title":"Am J Pathol"},{"key":"3869_CR18","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1002\/1529-0131(199907)42:7<1451::AID-ANR19>3.0.CO;2-6","volume":"42","author":"CA Feghali","year":"1999","unstructured":"Feghali CA, Wright TM: Identification of multiple, deferentially expressed messenger RNAs in dermal fibroblasts from patients with systemic sclerosis. Arthritis Rheum. 1999, 42: 1451-1457. 10.1002\/1529-0131(199907)42:7<1451::AID-ANR19>3.0.CO;2-6.","journal-title":"Arthritis Rheum"},{"key":"3869_CR19","first-page":"747","volume":"34","author":"R Meyringer","year":"2007","unstructured":"Meyringer R, Neumann E, Judex M, Landthaler M, Kullmann F, Scholmerich J, Gay S, Tarner IH, Distler O, M\u00fcller-Ladner U: Analysis of gene expression patterns in systemic sclerosis fibroblasts using RNA arbitrarily primed-polymerase chain reaction for different display. J Rheumatol. 2007, 34: 747-753.","journal-title":"J Rheumatol"},{"key":"3869_CR20","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/S0008-6363(01)00525-9","volume":"53","author":"I Mercier","year":"2002","unstructured":"Mercier I, Colombo F, Mader S, Calderone A: Ovarian hormones induce TGF-beta (3) and fibronectin mRNAs but exhibit a disparate action on cardiac fibroblast proliferation. Cardiovasc Res. 2002, 53: 728-739. 10.1016\/S0008-6363(01)00525-9.","journal-title":"Cardiovasc Res"},{"key":"3869_CR21","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/S0029-7844(99)00397-X","volume":"94","author":"WF Ziegler","year":"1999","unstructured":"Ziegler WF, Bernstein I, Badger G, Leavitt T, Cerrero ML: Regional hemodinamic adaptation during the menstrual cycle. Obstet Gynecol. 1999, 94: 695-699. 10.1016\/S0029-7844(99)00397-X.","journal-title":"Obstet Gynecol"},{"key":"3869_CR22","doi-asserted-by":"publisher","first-page":"790","DOI":"10.3109\/00016349409072507","volume":"73","author":"O Bakos","year":"1994","unstructured":"Bakos O, Lundkvist O, Wide L, Bergh T: Ultrasonographical and hormonal description of normal ovulatory menstrual cycle. Acta Obstet Gynecol Scand. 1994, 73: 790-796. 10.3109\/00016349409072507.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"3869_CR23","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/S0029-7844(01)01385-0","volume":"99","author":"M Notelovitz","year":"2002","unstructured":"Notelovitz M, Funk S, Nanavati N, Mazzeo M: Estradiol absorption from vaginal tablets in postmenoposal women. Obstet Gynecol. 2002, 99: 556-562. 10.1016\/S0029-7844(01)01385-0.","journal-title":"Obstet Gynecol"},{"key":"3869_CR24","first-page":"149","volume":"10","author":"J Haczynski","year":"2002","unstructured":"Haczynski J, Tarkowski R, Jarzabek K, Slomczynska M, Wolczynski S, Magoffin DA, Jakowicki JA, Jakimiuk AJ: Human cultured skin fibroblasts express estrogen receptor alpha and beta. Int J Mol Med. 2002, 10: 149-153.","journal-title":"Int J Mol Med"},{"key":"3869_CR25","first-page":"245","volume":"60","author":"EF Foley","year":"2000","unstructured":"Foley EF, Jazaeri AA, Shupnik MA, Jazaeri O, Rice LW: Selective loss of estrogen receptor beta in malignant human colon. Cancer Res. 2000, 60: 245-248.","journal-title":"Cancer Res"},{"key":"3869_CR26","first-page":"17","volume":"14","author":"N Jassam","year":"2005","unstructured":"Jassam N, Bell SM, Speirs V, Quirke P: Loss of expression of oestrogen receptor beta in col on cancer and its association with Duke's staging. Oncol Rep. 2005, 14: 17-21.","journal-title":"Oncol Rep"},{"key":"3869_CR27","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1016\/S0959-8049(03)00239-9","volume":"39","author":"PA Konstantinopoulos","year":"2003","unstructured":"Konstantinopoulos PA, Kominea A, Vandoros G, Sykiotis GP, Andricopoulos P, Varakis I, Sotiropoulou-Bonikou G, Papavassiliou AG: Oestrogen receptor beta (ER\u03b2) is abundantly expressed in normal colonic mucosa, but declines in colon adenocarcinoma paralleling the tumor's dedifferentiation. Eur J Cancer. 2003, 39: 1251-1258. 10.1016\/S0959-8049(03)00239-9.","journal-title":"Eur J Cancer"},{"key":"3869_CR28","first-page":"632","volume":"61","author":"M Campbell-Thompson","year":"2001","unstructured":"Campbell-Thompson M, Lynch IJ, Bhardwaj B: Expression of estrogen receptor (ER) subtypes and ER\u03b2 isoforms in colon cancer. Cancer Res. 2001, 61: 632-640.","journal-title":"Cancer Res"},{"key":"3869_CR29","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/S0002-9440(10)61676-8","volume":"159","author":"I Leav","year":"2001","unstructured":"Leav I, Lau KM, Adams JY, McNeal JE, Taplin ME, Wang J, Singh H, Ho SM: Comparative studies of the estrogen receptors beta and alpha and the androgen receptor in normal human prostate glands, dysplasia, and in primary and metastatic carcinoma. Am J Pathol. 2001, 159: 79-92. 10.1016\/S0002-9440(10)61676-8.","journal-title":"Am J Pathol"},{"key":"3869_CR30","first-page":"5331","volume":"61","author":"LG Horvath","year":"2001","unstructured":"Horvath LG, Henshall SM, Lee CS, Head DR, Quinn DI, Makela S, Delprado W, Golovsky D, Brenner PC, O'Neill G, Kooner R, Stricker PD, Grygiel JJ, Gustafsson JA, Sutherland RL: Frequent loss of estrogen receptor-beta expression in prostate cancer. Cancer Res. 2001, 61: 5331-5335.","journal-title":"Cancer Res"},{"key":"3869_CR31","doi-asserted-by":"publisher","first-page":"6330","DOI":"10.1073\/pnas.111150898","volume":"98","author":"Z Weihua","year":"2001","unstructured":"Weihua Z, Makela S, Andersson LC, Salmi S, Saji S, Webster JI, Jensen EV, Nilsson S, Warner M, Gustafsson JA: A role for estrogen receptor \u03b2 in the regulation of growth of the ventral prostate. Proc Natl Acad Sci USA. 2001, 98: 6330-6335. 10.1073\/pnas.111150898.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3869_CR32","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/j.1749-6632.2009.05296.x","volume":"1193","author":"S Soldano","year":"2010","unstructured":"Soldano S, Montagna P, Brizzolara R, Sulli A, Parodi A, Seriolo B, Paolino S, Villaggio B, Cutolo M: Effects of estrogens on extracellular matrix synthesis in cultures of human and normal scleroderma skin fibroblasts. Ann N Y Acad Sci. 2010, 1193: 25-29. 10.1111\/j.1749-6632.2009.05296.x.","journal-title":"Ann N Y Acad Sci"},{"key":"3869_CR33","doi-asserted-by":"publisher","first-page":"R769","DOI":"10.1152\/ajpregu.00375.2006","volume":"292","author":"RW Mankhey","year":"2007","unstructured":"Mankhey RW, Wells CC, Bhatti F, Maric C: 17\u03b2-estradiol supplementation reduces tubulointerstitial fibrosis by increasing MMP activity in the diabetic kidney. Am J Physiol Regul Integr Comp Physiol. 2007, 292: R769-R777.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"3869_CR34","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1210\/me.2010-0154","volume":"24","author":"A Pedram","year":"2010","unstructured":"Pedram A, Razandi M, O'Mahony F, Lubahn D, Levin ER: Estrogen receptor-beta prevents cardiac fibrosis. Mol Endocrinol. 2010, 24: 2152-2165. 10.1210\/me.2010-0154.","journal-title":"Mol Endocrinol"},{"key":"3869_CR35","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1152\/physrev.2001.81.4.1535","volume":"81","author":"S Nilsson","year":"2001","unstructured":"Nilsson S, M\u00e4kel\u00e4 S, Treuter E, Tujague M, Thomsen J, Andersson G, Enmark E, Pettersson K, Warner M, Gustafsson JA: Mechanisms of estrogen action. Physiol Rev. 2001, 81: 1535-1565.","journal-title":"Physiol Rev"},{"key":"3869_CR36","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1210\/me.2003-0044","volume":"18","author":"R O'Lone","year":"2004","unstructured":"O'Lone R, Frith MC, Karlsson EK, Hansen U: Genomic targets of nuclear estrogen receptors. Mol Endocrinol. 2004, 18: 1859-1875. 10.1210\/me.2003-0044.","journal-title":"Mol Endocrinol"},{"key":"3869_CR37","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1007\/s001090050242","volume":"76","author":"M Gottlicher","year":"1998","unstructured":"Gottlicher M, Heck S, Herrlich P: Transcriptional cross-talk, the second mode of steroid hormone receptor action. J Mol Med. 1998, 76: 480-489. 10.1007\/s001090050242.","journal-title":"J Mol Med"},{"key":"3869_CR38","doi-asserted-by":"publisher","first-page":"2854","DOI":"10.1210\/me.2004-0115","volume":"18","author":"M Razandi","year":"2004","unstructured":"Razandi M, Pedram A, Merchenthaler I, Greene GL, Levin ER: Plasma membrane estrogen receptors exist and functions as dimers. Mol Endocrinol. 2004, 18: 2854-2865. 10.1210\/me.2004-0115.","journal-title":"Mol Endocrinol"},{"key":"3869_CR39","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/S0039-128X(01)00179-9","volume":"67","author":"ER Levin","year":"2002","unstructured":"Levin ER: Cellular functions of plasma membrane estrogen receptors. Steroid. 2002, 67: 471-475. 10.1016\/S0039-128X(01)00179-9.","journal-title":"Steroid"},{"key":"3869_CR40","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.molmed.2004.01.007","volume":"10","author":"JM Olson","year":"2004","unstructured":"Olson JM, Hallahan AR: P38 MAP kinase: a convergence point in cancer therapy. Trends Mol Med. 2004, 10: 125-129. 10.1016\/j.molmed.2004.01.007.","journal-title":"Trends Mol Med"},{"key":"3869_CR41","first-page":"1","volume":"4","author":"JK Kim","year":"2006","unstructured":"Kim JK, Levin ER: Estrogen signaling in the cardiovascular system. Nucl Res Signaling. 2006, 4: 1-5.","journal-title":"Nucl Res Signaling"},{"key":"3869_CR42","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/35065000","volume":"410","author":"L Chang","year":"2001","unstructured":"Chang L, Karin M: Mammalian MAP kinase signaling cascades. Nature. 2001, 410: 37-40. 10.1038\/35065000.","journal-title":"Nature"},{"key":"3869_CR43","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1126\/science.270.5240.1326","volume":"270","author":"Z Xia","year":"1995","unstructured":"Xia Z, Dickens M, Raingeaud J, Davis RJ: Opposing effects of ERK and JNK-p38 kinases in apoptosis. Science. 1995, 270: 1326-1331. 10.1126\/science.270.5240.1326.","journal-title":"Science"},{"key":"3869_CR44","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.2174\/138955706778560139","volume":"6","author":"C Redaelli","year":"2006","unstructured":"Redaelli C, Granucci F, De Gioia L, Cipolla L: Synthesis and biological activity of Akt\/PI3K inhibitors. Mini Rev Med Chem. 2006, 6: 1127-1136. 10.2174\/138955706778560139.","journal-title":"Mini Rev Med Chem"},{"key":"3869_CR45","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1111\/j.1471-0528.1985.tb01091.x","volume":"92","author":"M Brincat","year":"1985","unstructured":"Brincat M, Moniz CJ, Studd JW, Darby A, Magos A, Emburey G, Versi E: Long-term effects of the menopause and sex hormones on skin thickness. Br J Obstet Gynaecol. 1985, 92: 256-259. 10.1111\/j.1471-0528.1985.tb01091.x.","journal-title":"Br J Obstet Gynaecol"},{"key":"3869_CR46","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1097\/00042192-199400120-00004","volume":"1","author":"M Meschia","year":"1994","unstructured":"Meschia M, Bruschi F, Amicarelli F, Barbacini P, Monza GC, Crosignani PG: Transdermal hormone replacement therapy and skin in postmenopausal women, a placebo controlled study. Menopause. 1994, 1: 79-82.","journal-title":"Menopause"},{"key":"3869_CR47","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/S0002-9378(94)70242-X","volume":"170","author":"R Maheux","year":"1994","unstructured":"Maheux R, Naud F, Rioux M, Grenier R, Lemay A, Guy J, Langevin M: A randomized, double-blind, placebo-controlled study on the effect of conjugated estrogens on skin thickness. Am J Obstet Gynecol. 1994, 170: 642-649.","journal-title":"Am J Obstet Gynecol"},{"key":"3869_CR48","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/0378-5122(92)90245-Y","volume":"15","author":"C Castelo-Branco","year":"1992","unstructured":"Castelo-Branco C, Duran M, Gonzalez-Merlo J: Skin collagen changes related to age and hormone replacement therapy. Maturitas. 1992, 15: 113-119. 10.1016\/0378-5122(92)90245-Y.","journal-title":"Maturitas"},{"key":"3869_CR49","first-page":"273","volume":"45","author":"D Kalogirou","year":"2000","unstructured":"Kalogirou D, Aroni K, Kalogirou O, Antoniou G, Botsis D, Kontoravdis A: Histological changes induced by tibolone and estrogen\/glucocorticoid on aging skin. Int J Fertil Womens Med. 2000, 45: 273-278.","journal-title":"Int J Fertil Womens Med"},{"key":"3869_CR50","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.jaad.2004.08.039","volume":"53","author":"G Hall","year":"2005","unstructured":"Hall G, Phillips TJ: Estrogen and skin: the effects of estrogen, menopause, and hormone replacement therapy on the skin. J Am Acad Dermatol. 2005, 53: 555-568. 10.1016\/j.jaad.2004.08.039.","journal-title":"J Am Acad Dermatol"},{"key":"3869_CR51","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1016\/S0002-9440(10)62470-4","volume":"166","author":"M Charaee-Kermani","year":"2005","unstructured":"Charaee-Kermani M, Hatano K, Nozaki Y, Phan SH: Gender-based differences in bleomycin-induced pulmonary fibrosis. Am J Pathol. 2005, 166: 1593-1606. 10.1016\/S0002-9440(10)62470-4.","journal-title":"Am J Pathol"},{"key":"3869_CR52","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.jdermsci.2007.05.008","volume":"47","author":"M Markiewicz","year":"2007","unstructured":"Markiewicz M, Asano Y, Znoyko S, Gong Y, Watson DK, Trojanowska M: Distinct effects of gonadectomy in male and female mice on collagen fibrillogenesis in the skin. J Dermatol Sci. 2007, 47: 217-226. 10.1016\/j.jdermsci.2007.05.008.","journal-title":"J Dermatol Sci"},{"key":"3869_CR53","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.mce.2012.05.005","volume":"362","author":"T Inoue","year":"2012","unstructured":"Inoue T, Miki Y, Abe K, Hatori M, Hosaka M, Kariya Y, Kakuo S, Fujimura T, Hachiya A, Honma S, Aiba S, Sasano H: Sex steroid synthesis in human skin in situ: the role of aromatase and steroidogenic acute regulatory protein in the homeostasis of human skin. Mol Cell Endocrinol. 2012, 362: 19-28. 10.1016\/j.mce.2012.05.005.","journal-title":"Mol Cell Endocrinol"},{"key":"3869_CR54","doi-asserted-by":"publisher","first-page":"A460","DOI":"10.1016\/j.autrev.2011.11.014","volume":"11","author":"M Cutolo","year":"2012","unstructured":"Cutolo M, Sulli A, Straub RH: Estrogen metabolism and autoimmunity. Autoimmun Rev. 2012, 11: A460-A464. 10.1016\/j.autrev.2011.11.014.","journal-title":"Autoimmun Rev"},{"key":"3869_CR55","first-page":"1207","volume":"19","author":"CA Feghali","year":"1992","unstructured":"Feghali CA, Bost KL, Boulware DW, Levy LS: Mechanisms of pathogenesis in scleroderma. I. Overproduction of interleukin 6 by fibroblasts cultured from affected skin sites of patients with scleroderma. J Rheumatol. 1992, 19: 1207-1211.","journal-title":"J Rheumatol"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar4140.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/ar4140\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar4140.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T10:49:42Z","timestamp":1728384582000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/ar4140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,10]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2013,2]]}},"alternative-id":["3869"],"URL":"https:\/\/doi.org\/10.1186\/ar4140","relation":{},"ISSN":["1478-6354"],"issn-type":[{"value":"1478-6354","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,10]]},"assertion":[{"value":"25 September 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2012","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2012","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2013","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"R10"}}